Kinetics of Antigen Expression and Epitope Presentation during Virus Infection

PLoS Pathogens

Volumn 9, Issue 1, 2013, Pages

  Croft, Nathan P ^a   Smith, Stewart A ^b   Wong, Yik Chun ^b   Tan, Chor Teck ^a   Dudek, Nadine L ^a   Flesch, Inge E A ^b   Lin, Leon C W ^b   Tscharke, David C ^b   Purcell, Anthony W ^a  

^a MONASH UNIVERSITY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOGENICITY; LIQUID CHROMATOGRAPHY; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCANNING ELECTRON MICROSCOPY; VACCINIA VIRUS; VALIDATION PROCESS; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL LINE; DENDRITIC CELLS; EPITOPE MAPPING; EPITOPES; HOST-PATHOGEN INTERACTIONS; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; MICE; SMALLPOX; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS DISEASES;

EID: 84875062998     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003129     Document Type: Article

References (86)

1. Purcell AW, Elliott T, (2008) Molecular machinations of the MHC-I peptide loading complex. Curr Opin Immunol 20: 75-81.
2. Dudek NL, Perlmutter P, Aguilar MI, Croft NP, Purcell AW, (2010) Epitope discovery and their use in peptide based vaccines. Curr Pharm Des 16: 3149-3157.
3. Yewdell JW, (2006) Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25: 533-543.
4. Tscharke DC, Karupiah G, Zhou J, Palmore T, Irvine KR, et al. (2005) Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201: 95-104.
5. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, et al. (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24: 817-819.
6. Vyas JM, Van der Veen AG, Ploegh HL, (2008) The known unknowns of antigen processing and presentation. Nat Rev Immunol 8: 607-618.
7. Purcell AW, McCluskey J, Rossjohn J, (2007) More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 6: 404-414.
8. Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, et al. (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354.
9. Anton LC, Yewdell JW, Bennink JR, (1997) MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J Immunol 158: 2535-2542.
10. Dolan BP, Sharma AA, Gibbs JS, Cunningham TJ, Bennink JR, et al. (2012) MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA. Proceedings of the National Academy of Sciences 109: 7025-7030.
11. Pang KC, Wei JQZ, Chen W, (2006) Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining. Journal of Immunological Methods 311: 12-18.
12. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN, (1997) Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
13. Lev A, Princiotta MF, Zanker D, Takeda K, Gibbs JS, et al. (2010) Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Proc Natl Acad Sci U S A 107: 6964-6969.
14. Makler O, Oved K, Netzer N, Wolf D, Reiter Y, (2010) Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity. Eur J Immunol 40: 1552-1565.
15. Michaeli Y, Denkberg G, Sinik K, Lantzy L, Chih-Sheng C, et al. (2009) Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies. J Immunol 182: 6328-6341.
16. Hickman HD, Luis AD, Bardet W, Buchli R, Battson CL, et al. (2003) Cutting edge: class I presentation of host peptides following HIV infection. J Immunol 171: 22-26.
17. van Els CA, Herberts CA, van der Heeft E, Poelen MC, van Gaans-van den Brink JA, et al. (2000) A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur J Immunol 30: 1172-1181.
18. Tellam J, Smith C, Rist M, Webb N, Cooper L, et al. (2008) Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc Natl Acad Sci U S A 105: 9319-9324.
19. Granados DP, Yahyaoui W, Laumont CM, Daouda T, Muratore-Schroeder TL, et al. (2012) MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood 119: e181-191.
20. de Verteuil D, Granados DP, Thibault P, Perreault C, (2012) Origin and plasticity of MHC I-associated self peptides. Autoimmun Rev 11: 627-635.
21. Dolan BP, Bennink JR, Yewdell JW, (2011) Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci 68: 1481-1489.
22. Dolan BP, Li L, Veltri CA, Ireland CM, Bennink JR, et al. (2011) Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J Immunol 186: 2065-2072.
23. Farfan-Arribas DJ, Stern LJ, Rock KL, (2012) Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides. Proc Natl Acad Sci U S A 109: 16998-7003.
24. Fortier MH, Caron E, Hardy MP, Voisin G, Lemieux S, et al. (2008) The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med 205: 595-610.
25. Reits EA, Vos JC, Gromme M, Neefjes J, (2000) The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404: 774-778.
26. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, et al. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770-774.
27. Khan S, de Giuli R, Schmidtke G, Bruns M, Buchmeier M, et al. (2001) Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J Immunol 167: 4801-4804.
28. Weinzierl AO, Lemmel C, Schoor O, Muller M, Kruger T, et al. (2007) Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics 6: 102-113.
29. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW, (2002) Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3: 265-271 Epub 2002 Feb 2004.
30. Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, et al. (2008) Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol 9: 155-165 Epub 2008 Jan 2013.
31. Xu RH, Remakus S, Ma X, Roscoe F, Sigal LJ, (2010) Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLoS Pathog 6: e1000768.
32. Tan CT, Croft NP, Dudek NL, Williamson NA, Purcell AW, (2011) Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 11: 2336-2340.
33. Wisniewski JR, Zougman A, Nagaraj N, Mann M, (2009) Universal sample preparation method for proteome analysis. Nat Methods 6: 359-362.
34. Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, et al. (2004) CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
35. Kastenmuller W, Gasteiger G, Gronau JH, Baier R, Ljapoci R, et al. (2007) Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med 204: 2187-2198 Epub 2007 Aug 2120.
36. Lange V, Picotti P, Domon B, Aebersold R, (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4: 222.
37. Dudek NL, Tan CT, Gorasia DG, Croft NP, Illing PT, et al. (2012) Constitutive and Inflammatory Immunopeptidome of Pancreatic beta-Cells. Diabetes 61: 3018-25.
38. Unwin RD, Griffiths JR, Leverentz MK, Grallert A, Hagan IM, et al. (2005) Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity. Mol Cell Proteomics 4: 1134-1144.
39. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, et al. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26: 966-968.
40. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, et al. (2010) Global quantification of mammalian gene expression control. Nature 473: 337-342.
41. Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B, (2010) Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc Natl Acad Sci U S A 107: 11513-11518.
42. Assarsson E, Greenbaum JA, Sundstrom M, Schaffer L, Hammond JA, et al. (2008) Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci U S A 105: 2140-2145.
43. Yang Z, Reynolds SE, Martens CA, Bruno DP, Porcella SF, et al. (2011) Expression profiling of the intermediate and late stages of poxvirus replication. J Virol 85: 9899-9908 Epub 2011 Jul 9827.
44. Flesch IE, Hollett NA, Wong YC, Tscharke DC, (2012) Linear fidelity in quantification of anti-viral CD8+ T cells. PLoS One 7: e39533 Epub 32012 Jun 39520.
45. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, et al. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358: 764-768.
46. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, et al. (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264: 716-719.
47. Crotzer VL, Christian RE, Brooks JM, Shabanowitz J, Settlage RE, et al. (2000) Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. J Immunol 164: 6120-6129.
48. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, et al. (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255: 1261-1263.
49. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr, (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622-627.
50. Urban RG, Chicz RM, Lane WS, Strominger JL, Rehm A, et al. (1994) A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci U S A 91: 1534-1538.
51. Scull KE, Dudek NL, Corbett AJ, Ramarathinam SH, Gorasia DG, et al. (2012) Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands. Mol Immunol 51: 136-142.
52. Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, et al. (2011) Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol 13: 129-135.
53. Caron E, Vincent K, Fortier MH, Laverdure JP, Bramoulle A, et al. (2011) The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 7: 533.
54. Hogan KT, Sutton JN, Chu KU, Busby JA, Shabanowitz J, et al. (2005) Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members. Cancer Immunol Immunother 54: 359-371.
55. Herberts CA, Meiring HM, van Gaans-van den Brink JA, van der Heeft E, Poelen MC, et al. (2003) Dynamics of measles virus protein expression are reflected in the MHC class I epitope display. Mol Immunol 39: 567-575.
56. Yewdell JW, (2005) The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol Rev 207: 8-18.
57. Yuen TJ, Flesch IE, Hollett NA, Dobson BM, Russell TA, et al. (2010) Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response. J Virol 84: 10220-10229.
58. Neefjes J, Jongsma ML, Paul P, Bakke O, (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11: 823-836.
59. Moutaftsi M, Salek-Ardakani S, Croft M, Peters B, Sidney J, et al. (2009) Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model. Eur J Immunol 39: 717-722.
60. Ljunggren HG, Stam NJ, Ohlen C, Neefjes JJ, Hoglund P, et al. (1990) Empty MHC class I molecules come out in the cold. Nature 346: 476-480.
61. Howarth M, Williams A, Tolstrup AB, Elliott T, (2004) Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci U S A 101: 11737-11742.
62. Eisen HN, Hou XH, Shen C, Wang K, Tanguturi VK, et al. (2012) Promiscuous binding of extracellular peptides to cell surface class I MHC protein. Proc Natl Acad Sci U S A 109: 4580-4585.
63. Milner E, Barnea E, Beer I, Admon A, (2006) The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol Cell Proteomics 5: 357-365.
64. Yewdell JW, Anton LC, Bennink JR, (1996) Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol 157: 1823-1826.
65. Apcher S, Daskalogianni C, Lejeune F, Manoury B, Imhoos G, et al. (2011) Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci U S A 108: 11572-11577.
66. Yewdell JW, (2011) DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 32: 548-558.
67. Mannering SI, Harrison LC, Williamson NA, Morris JS, Thearle DJ, et al. (2005) The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 202: 1191-1197.
68. Petersen J, Purcell AW, Rossjohn J, (2009) Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J Mol Med (Berl) 87: 1045-1051.
69. Chen W, Anton LC, Bennink JR, Yewdell JW, (2000) Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12: 83-93.
70. van der Burg SH, Visseren MJ, Brandt RM, Kast WM, Melief CJ, (1996) Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 156: 3308-3314.
71. Yoshimura Y, Yadav R, Christianson GJ, Ajayi WU, Roopenian DC, et al. (2004) Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens. J Immunol 172: 6666-6674.
72. Basta S, Chen W, Bennink JR, Yewdell JW, (2002) Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells. J Immunol 168: 5403-5408.
73. Chen W, Norbury CC, Cho Y, Yewdell JW, Bennink JR, (2001) Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med 193: 1319-1326.
74. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, et al. (1996) A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381: 166-168.
75. Holtappels R, Podlech J, Pahl-Seibert MF, Julch M, Thomas D, et al. (2004) Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 199: 131-136.
76. Tatum AM, Watson AM, Schell TD, (2010) Direct presentation regulates the magnitude of the CD8+ T cell response to cell-associated antigen through prolonged T cell proliferation. J Immunol 185: 2763-2772.
77. Obar JJ, Khanna KM, Lefrancois L, (2008) Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 28: 859-869.
78. Kotturi MF, Scott I, Wolfe T, Peters B, Sidney J, et al. (2008) Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 181: 2124-2133.
79. La Gruta NL, Rothwell WT, Cukalac T, Swan NG, Valkenburg SA, et al. (2010) Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J Clin Invest 120: 1885-1894.
80. Flesch IE, Woo WP, Wang Y, Panchanathan V, Wong YC, et al. (2010) Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice. J Immunol 184: 45-55.
81. Shen Z, Reznikoff G, Dranoff G, Rock KL, (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158: 2723-2730.
82. Hammerling GJ, Rusch E, Tada N, Kimura S, Hammerling U, (1982) Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc Natl Acad Sci U S A 79: 4737-4741.
83. Townsend A, Ohlen C, Foster L, Bastin J, Ljunggren HG, et al. (1989) A mutant cell in which association of class I heavy and light chains is induced by viral peptides. Cold Spring Harb Symp Quant Biol 54: 299-308.
84. Purcell AW, Gorman JJ, Garcia-Peydro M, Paradela A, Burrows SR, et al. (2001) Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol 166: 1016-1027.
85. Sherwood CA, Eastham A, Lee LW, Risler J, Mirzaei H, et al. (2009) Rapid optimization of MRM-MS instrument parameters by subtle alteration of precursor and product m/z targets. J Proteome Res 8: 3746-3751.
86. Webb AI, Borg NA, Dunstone MA, Kjer-Nielsen L, Beddoe T, et al. (2004) The structure of H-2K(b) and K(bm8) complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance. J Immunol 173: 402-409.